237 related articles for article (PubMed ID: 3280211)
1. Clinical pharmacokinetics of ketoconazole.
Daneshmend TK; Warnock DW
Clin Pharmacokinet; 1988 Jan; 14(1):13-34. PubMed ID: 3280211
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of ketoconazole.
Sohn CA
Clin Pharm; 1982; 1(3):217-24. PubMed ID: 6309466
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic optimisation of oral antifungal therapy.
Schäfer-Korting M
Clin Pharmacokinet; 1993 Oct; 25(4):329-41. PubMed ID: 8261715
[TBL] [Abstract][Full Text] [Related]
4. Ketoconazole. Mechanism of action, spectrum of activity, pharmacokinetics, drug interactions, adverse reactions and therapeutic use.
Van Tyle JH
Pharmacotherapy; 1984; 4(6):343-73. PubMed ID: 6151171
[TBL] [Abstract][Full Text] [Related]
5. Liver injury associated with ketoconazole: review of the published evidence.
Greenblatt HK; Greenblatt DJ
J Clin Pharmacol; 2014 Dec; 54(12):1321-9. PubMed ID: 25216238
[TBL] [Abstract][Full Text] [Related]
6. Use of antifungal therapy in hospitalized patients. I. Results prior to the marketing of fluconazole.
Grasela TH; Goodwin SD; Pasko MT; Walawander CA; Raebel MA
Ann Pharmacother; 1994 Feb; 28(2):252-60. PubMed ID: 8173147
[TBL] [Abstract][Full Text] [Related]
7. Oral and parenteral treatment with itraconazole in various superficial and systemic experimental fungal infections. Comparisons with other antifungals and combination therapy.
Van Cutsem J
Br J Clin Pract Suppl; 1990 Sep; 71():32-40. PubMed ID: 1965417
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 3A4 in vivo ketoconazole competitive inhibition: determination of Ki and dangers associated with high clearance drugs in general.
Boxenbaum H
J Pharm Pharm Sci; 1999; 2(2):47-52. PubMed ID: 10952769
[TBL] [Abstract][Full Text] [Related]
9. [Transcutaneous absorption of ketoconazole in infant after application of Ketoderm].
Levron JC; Taieb A
Therapie; 1991; 46(1):29-31. PubMed ID: 1826971
[TBL] [Abstract][Full Text] [Related]
10. Distribution of oral ketoconazole to vaginal tissue.
Heykants JJ; Woestenborghs RJ; Bisschop MP; Merkus JM
Eur J Clin Pharmacol; 1982 Oct; 23(4):331-3. PubMed ID: 6293835
[TBL] [Abstract][Full Text] [Related]
11. Disposition of ketoconazole, an oral antifungal, in humans.
Brass C; Galgiani JN; Blaschke TF; Defelice R; O'Reilly RA; Stevens DA
Antimicrob Agents Chemother; 1982 Jan; 21(1):151-8. PubMed ID: 6282204
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of complicated urinary tract infections caused by fungi].
Kawada Y; Shimizu Y; Horie M; Tokuyama H; Matsuda S; Nishiura T
Jpn J Antibiot; 1984 Mar; 37(3):285-9. PubMed ID: 6330394
[TBL] [Abstract][Full Text] [Related]
13. Ketoconazole increases the plasma levels of ivermectin in sheep.
Alvinerie M; Dupuy J; Kiki-Mvouaka S; Sutra JF; Lespine A
Vet Parasitol; 2008 Oct; 157(1-2):117-22. PubMed ID: 18657366
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of oral antifungals and their clinical implications.
Heykants J; Van Peer A; Lavrijsen K; Meuldermans W; Woestenborghs R; Cauwenbergh G
Br J Clin Pract Suppl; 1990 Sep; 71():50-6. PubMed ID: 1965419
[TBL] [Abstract][Full Text] [Related]
15. Development of an in vivo preclinical screen model to estimate absorption and first-pass hepatic extraction of xenobiotics. II. Use of ketoconazole to identify P-glycoprotein/CYP3A-limited bioavailability in the monkey.
Ward KW; Stelman GJ; Morgan JA; Zeigler KS; Azzarano LM; Kehler JR; McSurdy-Freed JE; Proksch JW; Smith BR
Drug Metab Dispos; 2004 Feb; 32(2):172-7. PubMed ID: 14744938
[TBL] [Abstract][Full Text] [Related]
16. Limits of antifungal prophylaxis by ketoconazole in leukemic patients.
Mazzoni A; Fiorentini C; Cevenini R; Nanetti A
Chemioterapia; 1985 Aug; 4(4):299-302. PubMed ID: 4053215
[TBL] [Abstract][Full Text] [Related]
17. Fungal infections and their management.
Graybill JR; Sharkey PK
Br J Clin Pract Suppl; 1990 Sep; 71():23-31. PubMed ID: 1965416
[TBL] [Abstract][Full Text] [Related]
18. The successful treatment of mycotic infections in immunosuppressed renal transplant recipients with ketoconazole.
Zazgornik J; Marosi L; Kopsa H; Schmidt P; Balcke P; Zyman H; Thurner J
Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):268-70. PubMed ID: 6286515
[TBL] [Abstract][Full Text] [Related]
19. Amphotericin B vs high-dose ketoconazole for empirical antifungal therapy among febrile, granulocytopenic cancer patients. A prospective, randomized study.
Walsh TJ; Rubin M; Hathorn J; Gress J; Thaler M; Skelton J; McKnight J; Browne M; Marshall D; Cotton D
Arch Intern Med; 1991 Apr; 151(4):765-70. PubMed ID: 2012462
[TBL] [Abstract][Full Text] [Related]
20. Ketoconazole and the antifungals.
Parkin JL
Otolaryngol Head Neck Surg; 1985 Feb; 93(1):132-3. PubMed ID: 3920612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
